TOVXTheriva Biologics, Inc.


$ 4.00 $ 0.25 (6.49 %)    

Tuesday, 17-Sep-2024 15:51:31 EDT
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ na
$ 4.13
$ 4.01 x 200
-- x --
$ 4.00 - $ 4.19
$ 2.67 - $ 17.11
109,849
na
4.12M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 theriva-biologics-announces-that-the-thericel-project-has-been-awarded-funding-of-228-million-from-the-national-knowledge-transfer-program-of-the-spanish-governments-ministry-of-science-innovation--universities-to-support-a-collaboration-between-the-universitat-autnoma-de-barcelona-to-advance-the-companys-suspension-cell-platform-for-the-clinical-manufacture-of-adenovirus--and-adeno-associated-virus-therapies

Theriva™ Biologics (NYSE:TOVX), ("Theriva" or the "Company") a diversified clinical-stage company developing th...

 whats-going-on-with-theriva-biologics-stock

Theriva Biologics shares are trading higher Friday on continued momentum following a series of catalysts this week. Here's ...

 whats-going-on-with-theriva-biologics-tovx-stock

Theriva Biologics shares are trading lower by 8.4% Monday morning. The company announced a 1-for-25 reverse stock split.

 theriva-biologics-announces-1-for-25-reverse-stock-split-effective-august-26-2024

Theriva Biologics, Inc. (NYSE:TOVX), a diversified clinical-stage company developing therapeutics designed to treat diseases in...

 theriva-biologics-q2-eps-043-misses-019-estimate

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION